Asieris doses first patient in bladder cancer diagnostic trial
Asieris Pharmaceuticals has announced that Hexvix, a drug used for bladder cancer diagnosis, completed dosing…
December 14, 2022 - 2 minutes
Asieris Pharmaceuticals has announced that Hexvix, a drug used for bladder cancer diagnosis, completed dosing…
Asieris Pharmaceuticals says it has completed the first patient dose in its phase III bridging trial…